The global market for pain management drugs is escalating at 3.88% CAGR during the forecast period of 2019-2027

Wednesday, December 12, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 11, 2018 /PRNewswire/ -- KEY FINDINGSPain is a distressing sensory and emotional feeling that occurs

due to tissue damage or illness that can take place for short-term (acute pain) to long-term (chronic pain).Pain management drugs market supplies medications and therapies which upon employs an interdisciplinary approach for easing the suffering and
improving the quality of life of such victims or patients.Read the full report: The global market for pain management drugs is escalating at 3.88% CAGR during the forecast period of 2019-2027. The market has been valued $ XX millions in its base year of 2018 and is expected to reach an astounding sum of $ XX millions by the end of the forecast period, essentially, 2027.MARKET INSIGHTSThe factors that are the sole drivers for the growth of the pain management drugs market are the public demand for medications with fewer side-effects and their consequential availability, and the rise in global geriatric population that could increase the use of pain medications are expected to drive the global market for pain management drugs.Alongside these circumstances, with the advancement in technology, there are researchers who are trying to develop abuse-deterrent drugs due to the increase in the number of drug abuse cases globally.This can pave way for the entry of newer drugs for the said market.Patent expiration of pain relieving drugs can decrease their market value, leading to the decrease in revenue earned for the global market.This can potentially affect the market growth.REGIONAL INSIGHTSThe global pain management drugs market has been segmented on the basis of several region regions, which are the North America, Europe, Asia-Pacific and the collective countries from the Rest of the World.North America holds the largest share by revenue $ XX millions in the year 2018.This is attributable to the fact that this region has a large number of aging inhabitants and favorable regulatory conditions.But conversely, Asia-Pacific region has the fastest growing market for pain management drugs.Companies mentioned1. ABBOTT LABORATORIES2. ACURA PHARMACEUTICALS, INC.3. CIPHER PHARMACEUTICALS INC.4. DAIICHI SANKYO, INC.5. EGALET CORP.6. ELI LILLY AND COMPANY7. GLAXOSMITHKLINE8. HIKMA PHARMACEUTICALS PLC9. JOHNSON & JOHNSON10. LUPIN LTD.11. PFIZER, INC.12. PURDUE PHARMA L.P.13. MERCK & CO., INC.14. NOVARTIS15. INSYS THERAPEUTICS, INC.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store